FLGT logo

FLGT
Fulgent Genetics Inc

5,693
Mkt Cap
$485.93M
Volume
392,973.00
52W High
$31.04
52W Low
$13.46
PE Ratio
-7.14
FLGT Fundamentals
Price
$17.11
Prev Close
$17.38
Open
$17.33
50D MA
$15.78
Beta
0.73
Avg. Volume
440,013.34
EPS (Annual)
-$1.97
P/B
0.47
Rev/Employee
$240,082.59
$475.20
Loading...
Loading...
News
all
press releases
Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual Meeting
Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent or the Company), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that its full abstract has been released on the ASCO 2026 website. The abstract will be presented...
News Placeholder
More News
News Placeholder
Fulgent Genetics Q1 Earnings Call Highlights
Fulgent Genetics (NASDAQ:FLGT) reported first-quarter 2026 revenue of $71.1 million as the company worked through a planned decline in testing volumes from its largest customer while integrating the...
News Placeholder
Full Transcript: Fulgent Genetics Q1 2026 Earnings Call
read more...
News Placeholder
Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Beats Revenue Estimates
Fulgent Genetics (FLGT) delivered earnings and revenue surprises of -89.47% and +4.00%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
Fulgent Genetics (NASDAQ:FLGT) Releases FY 2026 Earnings Guidance
Fulgent Genetics (NASDAQ:FLGT) updated its FY 2026 earnings guidance. The company provided EPS guidance of -1.590--1.590 for the period, compared to the consensus estimate of -1.590. The company also...
News Placeholder
Fulgent Reports First Quarter 2026 Financial Results
Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent, or the Company), a technology-based company with a well-established laboratory services business and a therapeutic development business, today...
News Placeholder
iRhythm Holdings, Inc. (IRTC) Reports Q1 Loss, Tops Revenue Estimates
IRHYTHM HLDGS (IRTC) delivered earnings and revenue surprises of +37.78% and +2.87%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
Fulgent Genetics (FLGT) to Release Earnings on Friday
Fulgent Genetics (NASDAQ:FLGT) will be releasing its Q1 2026 earnings before the market opens on Friday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-1-fulgent-genetics-inc-stock...
News Placeholder
Fulgent Genetics, Inc. (NASDAQ:FLGT) Given Average Rating of "Hold" by Analysts
Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT - Get Free Report) have been assigned an average recommendation of "Hold" from the five analysts that are covering the company, MarketBeat reports. One...
News Placeholder
Fulgent Selected to Present Rapid Oral Abstract Within the Head and Neck Cancer Track Session at the 2026 ASCO Annual Meeting
Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent or the Company), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available